| Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva JA De Hullu, H Hollema, DA Piers, RHM Verheijen, PJ Van Diest, ... Journal of Clinical Oncology 18 (15), 2811-2816, 2000 | 440 | 2000 |
| Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial MJE Mourits, CB Bijen, HJ Arts, HG ter Brugge, R van der Sijde, ... The Lancet Oncology 11 (8), 763-771, 2010 | 437 | 2010 |
| Vulvar carcinoma JA de Hullu, H Hollema, S Lolkema, M Boezen, H Boonstra, MPM Burger, ... Cancer 95 (11), 2331-2338, 2002 | 338 | 2002 |
| Tamoxifen treatment and gynecologic side effects: a review MJE Mourits, EGE De Vries, PHB Willemse, KA Ten Hoor, H Hollema, ... Obstetrics & Gynecology 97 (5), 855-866, 2001 | 337 | 2001 |
| Lymphvascular space involvement: an independent prognostic factor in endometrial cancer JM Briët, H Hollema, N Reesink, JG Aalders, MJE Mourits, A Klaske, ... Gynecologic oncology 96 (3), 799-804, 2005 | 293 | 2005 |
| Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer JB Madalinska, J Hollenstein, E Bleiker, M van Beurden, ... Journal of Clinical Oncology 23 (28), 6890-6898, 2005 | 277 | 2005 |
| Management of extracolonic tumours in patients with Lynch syndrome JJ Koornstra, MJE Mourits, RH Sijmons, AM Leliveld, H Hollema, ... The lancet oncology 10 (4), 400-408, 2009 | 276 | 2009 |
| The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy JB Madalinska, M van Beurden, EMA Bleiker, HB Valdimarsdottir, ... Journal of Clinical Oncology 24 (22), 3576-3582, 2006 | 261 | 2006 |
| Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction BAM Heemskerk-Gerritsen, C Seynaeve, CJ Van Asperen, M Ausems, ... JNCI: Journal of the National Cancer Institute 107 (5), 2015 | 243 | 2015 |
| Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age DM van der Kolk, GH de Bock, BK Leegte, M Schaapveld, MJE Mourits, ... Breast cancer research and treatment 124 (3), 643-651, 2010 | 241 | 2010 |
| Gynecologic screening in hereditary nonpolyposis colorectal cancer FEM Rijcken, MJE Mourits, JH Kleibeuker, H Hollema, AGJ van der Zee Gynecologic oncology 91 (1), 74-80, 2003 | 230 | 2003 |
| No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study BBJ Hermsen, RI Olivier, RHM Verheijen, M van Beurden, JA De Hullu, ... British journal of cancer 96 (9), 1335, 2007 | 206 | 2007 |
| Time to stop ovarian cancer screening in BRCA1/2 mutation carriers? NM Van Der Velde, MJE Mourits, HJG Arts, J de Vries, BK Leegte, ... International journal of cancer 124 (4), 919-923, 2009 | 182 | 2009 |
| Ovarian cancer in Lynch syndrome; a systematic review JM Helder-Woolderink, EA Blok, HFA Vasen, H Hollema, MJ Mourits, ... European Journal of Cancer 55, 65-73, 2016 | 170 | 2016 |
| CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma HH Workel, FL Komdeur, MCA Wouters, A Plat, HG Klip, FA Eggink, ... European Journal of Cancer 60, 1-11, 2016 | 150 | 2016 |
| Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis MJW Berends, Y Wu, RH Sijmons, T van der Sluis, WB Ek, ... Journal of clinical oncology 21 (23), 4364-4370, 2003 | 149 | 2003 |
| Support of the ‘fallopian tube hypothesis’ in a prospective series of risk-reducing salpingo-oophorectomy specimens W Reitsma, GH de Bock, JC Oosterwijk, J Bart, H Hollema, MJE Mourits European journal of cancer 49 (1), 132-141, 2013 | 133 | 2013 |
| Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries ME Jones, FE van Leeuwen, WE Hoogendoorn, MJE Mourits, H Hollema, ... Breast Cancer Research 14 (3), R91, 2012 | 131 | 2012 |
| Sexual functioning of cervical cancer survivors: a review with a female perspective EAG Lammerink, GH de Bock, E Pras, AKL Reyners, MJE Mourits Maturitas 72 (4), 296-304, 2012 | 122 | 2012 |
| Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy MJ Mourits, I Böckermann, EG De Vries, AG Van der Zee, KA Ten Hoor, ... British journal of cancer 86 (10), 1546, 2002 | 120 | 2002 |
